Related Experiment Video
Updated: May 15, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Editorial: no bugs bugging you? Emerging insights into Helicobacter-negative gastritis
Robert M Genta1, Richard H Lash
1Miraca Life Sciences Research Institute, Miraca Life Sciences, Irving, TX 75039, USA. robert.genta@utsouthwestern.edu
Helicobacter-negative gastritis remains unexplained, as common risk factors like tobacco, alcohol, NSAIDs, and PPIs showed no association in a study of 41 patients. Further research is needed to identify the causes of this condition.
Area of Science:
- Gastroenterology
- Pathology
- Microbiology
Background:
- A significant percentage of gastric biopsy specimens are diagnosed as Helicobacter-negative gastritis.
- The etiology of Helicobacter-negative gastritis is not well understood.
- This condition affects 3-20% of patients diagnosed with gastritis.
Purpose of the Study:
- To investigate potential associations between lifestyle factors and Helicobacter-negative gastritis.
- To explore risk factors including tobacco, alcohol, NSAIDs, and PPIs in patients with unexplained gastritis.
- To contribute to the understanding of the elusive entity of Helicobacter-negative gastritis.
Main Methods:
- Retrospective analysis of 41 patients diagnosed with gastritis.
- Exclusion of Helicobacter pylori infection via histology, culture, and serology.
- Data collection on tobacco use, alcohol consumption, NSAID use, and PPI use.
Main Results:
- No statistically significant associations were found between Helicobacter-negative gastritis and the evaluated parameters (tobacco, alcohol, NSAIDs, PPIs).
- The study failed to identify common risk factors contributing to this condition in the studied cohort.
- Results highlight the unexplained nature of Helicobacter-negative gastritis.
Conclusions:
- The etiology of Helicobacter-negative gastritis remains elusive.
- Further research is warranted to elucidate the causes of this condition.
- Additional diagnostic methods and investigation into other infectious agents are recommended.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...